Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025)

Rockwell Medical (RMTI) posted Total Non-Current Liabilities of $20.2 million for Q4 2025, down 1.48% on a QoQ basis from $20.5 million in Q3 2025, and down 21.3% year-over-year from $25.6 million in Q4 2024.

Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Rockwell Medical's Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $20.2 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 21.3% year-over-year to $20.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.2 million (down 21.3% YoY) and the FY2025 annual result came in at $20.2 million, down 21.3% from the prior year.
  • Total Non-Current Liabilities was $20.2 million for Q4 2025 at Rockwell Medical, down from $20.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $46.0 million in Q4 2021 and bottomed at $20.2 million in Q4 2025.
  • A 5-year average of $30.1 million and a median of $28.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities plunged 33.89% — and 2024, when it climbed 7.7%.
  • Rockwell Medical's Total Non-Current Liabilities stood at $46.0 million in 2021, then declined by 29.32% to $32.5 million in 2022, then slipped by 5.11% to $30.9 million in 2023, then decreased by 16.99% to $25.6 million in 2024, then slipped by 21.3% to $20.2 million in 2025.
  • Business Quant data shows RMTI's Total Non-Current Liabilities at $20.2 million in Q4 2025, $20.5 million in Q3 2025, and $22.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Rockwell Medical 25.77 Mn 1.88 Mn 2.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 20.16 Mn
Sep 30, 2025 20.47 Mn
Jun 30, 2025 22.22 Mn
Mar 31, 2025 21.94 Mn
Dec 31, 2024 25.62 Mn
Sep 30, 2024 27.94 Mn
Jun 30, 2024 29.52 Mn
Mar 31, 2024 30.07 Mn
Dec 31, 2023 30.87 Mn
Sep 30, 2023 28.59 Mn
Jun 30, 2023 28.50 Mn
Mar 31, 2023 27.92 Mn
Dec 31, 2022 32.53 Mn
Sep 30, 2022 38.04 Mn
Jun 30, 2022 38.96 Mn
Mar 31, 2022 42.23 Mn
Dec 31, 2021 46.03 Mn
Dec 31, 2020 43.58 Mn
Sep 30, 2014 19.65 Mn
Jun 30, 2014 21.66 Mn